DYRK1B and fatty liver disease: Further mechanistic studies revealed that Dyrk1b spontaneously causes fatty liver in rodents by increasing de novo lipogenesis and hepatic fatty acid uptake [56,105,106,107,108], despite suppressing the [104] canonical insulin signaling by PKC epsilon-mediated insulin receptor inactivation [57,59].